Revitalist Executes on Vision to Become a Clinical Leader in Psychedelics

Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) set out to build a nationwide network of psychedelic-assisted psychotherapy clinics in 2018. Since then, the company has grown its footprint to ten clinics across six states exceeding 60,650 sq. ft. of space and clinical capacity for more than 120 treatment rooms, with more to come.

The company believes that each treatment room could accommodate up to four visits per day at $490 per visit. Using these assumptions, the company’s 120+ treatment rooms could generate upwards of $60 million in annual revenue. 

These estimates aren’t merely guesses, either. The company recently reported $1.55 million in revenue and an estimated $1.17 million in gross income for the ten months leading up to October 31, 2021. These figures were double those from one year ago and come mainly from organic growth at its flagship clinic in Knoxville, TN.

Beyond Physical Clinics

Revitalist hasn’t limited its focus to physical clinics. Next year, the company plans to launch its telemedicine platform targeting psychedelic therapies. As a result, the company could reach millions more people around the country beyond the reach of its network of clinics and provide better support to those who go into its clinics.

In November, the company also announced the acquisition of a 60% interest in Revitaland Meta Tech Inc. to create virtual clinics in the metaverse. The virtual world will enable patients and medical professionals to interact without being in the same physical space, improving accessibility without compromising the experience.

While the metaverse may seem far-fetched to many, Facebook’s move to rename its business “Meta” underscores just how central the concept is to tech giants. In addition, the COVID-19 pandemic and the rise of remote working are also pushing many consumers toward virtual meetings in the metaverse that could quickly become a ubiquitous environment.

Significant Potential

Revitalist’s significant progress in building out its physical and virtual clinic network and presence reflects the strength of its leadership team. In addition to its unparalleled medical expertise, the team includes veteran financiers and project managers that have a track record of growing $100+ million businesses.

CEO Katie Walker discusses the company’s growth strategy

Management hopes to build a network of nearly 50 clinics in 2022 before reaching more than 150 clinics by 2025. After establishing a footprint in the U.S., the company aims to expand to international locations in jurisdictions. These ambitions could yield a company generating upwards of $100 million in annual revenue at attractive gross margins.

And, while these plans may seem ambitious on the surface, Stifel GMP research suggests that psychedelic-assisted psychotherapy (PAP) clinics have a total addressable market of over $10 billion in the U.S. alone. As a result, the company has significantly greater potential than its immediate plans over the long term to capitalize on the massive market.

Looking Ahead

Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) represents a compelling opportunity to invest in the growth of psychedelic-assisted therapies—a field that many experts believe could revolutionize mental health treatments worldwide. As the company continues to expand, investors may want to take a closer look at the stock.

For more information, visit the company’s website or download their investor presentation.

Disclaimer

The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.